9.6.2021 13:02:52 CEST | Aqua Bio Technology ASA | Additional regulated information required to be disclosed under the laws of a member state
Aqua Bio Technology ASA has publised minutes from Annual General Meeting held 9 June 2021.
See also updated corporate presentation attached to this press release.
For further information, please contact Espen Kvale, CEO, telephone +47 9162 8092.
* * *
Aqua Bio Technology (ABT) is developing and commercializing sustainable biotechnology for use in skin care products. ABT’s cosmetics ingredients are highly effective and they provide the cosmetics industry with natural alternatives to traditional ingredients. ABT is also marketing and distributing natural skin care products developed by partners towards consumers and professional users. ABT’s focus on commercialization and development of natural ingredients and natural skin care products has been, and will continue to be, an important part of the Company’s strategy going forward. ABT is listed on the Euronext Expand market of the Oslo Stock Exchange.
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
Disclosure regulation
This information is subject of the disclosure requirements pursuant to section of 5-12 of the Norwegian Securities Trading Act.
Contacts
Espen Kvale, CEO, +47 916 28 092, espen.kvale@aquabiotech.no
About Aqua Bio Technology ASA
Aqua Bio Technology (ABT) is developing and commercializing sustainablebiotechnology for use in skin care products. ABT’s cosmetics ingredients arehighly effective and they provide the cosmetics industry with naturalalternatives to traditional ingredients. ABT is also marketing and distributingnatural skin care products developed by partners towards consumers andprofessional users. Aqua Bio Technology is listed on Euronext Expand.
Attachments
AQUA BIO TECHNOLOGY ASA MINUTES OF ANNUAL GENERAL MEETING PUBLISHED pdf.pdf
ABT Corporate presentation June 2021.pdf
